CUBN and neoplasm: The tumor neoantigen burden (IGS2) was not related to other axes of the immunogram, including T cell immunity (IGS1), priming and activation (IGS3), trafficking and infiltration (IGS4), recognition of tumor cells (IGS5), inhibitor cells (IGS6), checkpoint expression (IGS6), and inhibitor molecules (IGS8) (Supplementary Figure 2).